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Faced with the continued emergence of antibiotic resistance to all known classes of
antibiotics, a paradigm shift in approaches toward antifungal therapeutics is required.
Well characterized in a broad spectrum of bacterial and fungal pathogens, biofilms are a
key factor in limiting the effectiveness of conventional antibiotics. Therefore, therapeutics
such as small molecules that prevent or disrupt biofilm formation would render
pathogens susceptible to clearance by existing drugs. This is the first report describing
the effect of the Pseudomonas aeruginosa alkylhydroxyquinolone interkingdom
signal molecules 2-heptyl-3-hydroxy-4-quinolone and 2-heptyl-4-quinolone on biofilm
formation in the important fungal pathogen Aspergillus fumigatus. Decoration of the
anthranilate ring on the quinolone framework resulted in significant changes in the
capacity of these chemical messages to suppress biofilm formation. Addition of methoxy
or methyl groups at the C5–C7 positions led to retention of anti-biofilm activity, in some
cases dependent on the alkyl chain length at position C2. In contrast, halogenation
at either the C3 or C6 positions led to loss of activity, with one notable exception.
Microscopic staining provided key insights into the structural impact of the parent and
modified molecules, identifying lead compounds for further development.
Keywords: biofilm, Aspergillus fumigatus, Pseudomonas aeruginosa, interkingdom interactions,
alkylhydroxyquinolone (AHQ), PQS, HHQ
INTRODUCTION
Aspergillus fumigatus is an opportunistic pathogenic fungus associated with hospital-acquired
infections. A. fumigatus infections contribute to morbidity and mortality in people with respiratory
diseases such as cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD), as well
as infecting open skin wounds in burn patients and medical implants (Peleg et al., 2010; Speirs
et al., 2012). Indeed, there is a growing awareness of the importance of fungal pathogens in
the lung and other sites of infection through global microbiome analyses (Kolwijck and van de
Veerdonk, 2014; Kim et al., 2015). However, as with their bacterial counterparts, function and
effect in relation to their contribution to the pathophysiology of disease can be harder to define.
Aspergillus infection takes two principal forms; invasive pulmonary aspergillosis (IPA) and chronic
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necrotising pulmonary aspergillosis, with the latter being
characterized by the transformation of conidia to hyphae
(germination), which can subsequently invade the tissue (Kaur
and Singh, 2014; Kolwijck and van de Veerdonk, 2014).
Hyphal stage cells typically adopt a structured biofilm, either
as monospecies or multispecies, at which point the biofilm-
embedded cells become highly resistant to antimicrobial drug
therapy (Seidler et al., 2008; Manavathu et al., 2014). Several
reasons have been proposed to explain this increased tolerance,
such as biofilm specific upregulation of eﬄux proteins, the
presence of extracellular matrices, and persister cells that are
inherently drug resistant/tolerant due to their low metabolic rate
(Manavathu et al., 2014).
These inherently resistant biofilm characteristics of
A. fumigatus have led to conventional antifungal therapies
rapidly becoming redundant in the treatment of not only
nosocomial infections (e.g., hematologic disease) but also on
indwelling medical devices (IMDs) and implants (Ramage and
Williams, 2013). While both Candida and Aspergillus species are
causative agents in approximately 8% of all implant infections,
their potency and resistance to antifungals is increasing steadily
with survival rates for some implant patient groups as low as
50% (Lynch and Robertson, 2008; Ramage and Williams, 2013).
More recently, Aspergillus contamination of nebuliser devices
used by CF patients has been reported (Peckham et al., 2016).
The upward trend in Aspergillosis and other major fungal
infections poses a significant clinical, financial and health threat
and requires concerted and sustained efforts to identify and
characterize novel anti-fungal agents to tackle these preventable
diseases.
It is now becoming clear that the co-existence and mutual
interaction of bacteria and fungi at the site of infection
contributes to the pathogenesis of disease. In the case of
CF, A. fumigatus has been isolated in up to 60% of patients
with Pseudomonas aeruginosa infection, suggesting a close
relationship between established colonization by P. aeruginosa
and superinfection by A. fumigatus (Paugam et al., 2010; Briard
et al., 2015). Interkingdom interactions between A. fumigatus
and bacterial competitors has been described previously, with
significant attention focused on the interaction with P. aeruginosa
(McAlester et al., 2008; Mowat et al., 2010; Briard et al., 2015;
Ferreira et al., 2015; Zheng et al., 2015). Perhaps somewhat
surprisingly, given their co-occurrence, many of these studies
describe an antagonistic influence of P. aeruginosa secreted
factors on A. fumigatus biofilm formation. Mowat et al. (2010)
ascribed the competitive inhibition of filamentous A. fumigatus
growth by P. aeruginosa to the effects of small diffusible and
heat-stable molecules. Interestingly, anti-biofilm activity in the
supernatants of P. aeruginosa lasR and lasI quorum sensing
mutants was reduced but not lost entirely, suggesting the factors
responsible are not entirely under Acyl Homoserine Lactone
(AHL) control. Several studies have described the impact of
redox active metabolites produced by P. aeruginosa on biofilm
formation and hyphal development in A. fumigatus (Briard et al.,
2015; Zheng et al., 2015), effects that are likely to be strain and
condition specific (Ferreira et al., 2015). More recently, Briard
et al. (2016) demonstrated stimulation of A. fumigatus growth
by volatile compounds produced by P. aeruginosa. Moreover,
strain specificity was also highlighted in a recent study by
Shirazi et al. (2016) where biofilm filtrates of P. aeruginosa
strains isolated from CF patients were shown to inhibit pre-
formed A. fumigatus biofilms through apoptosis. Therefore,
it is clear that the factors that govern the dynamics of the
P. aeruginosa – A. fumigatus interaction in vivo remain to be fully
understood. From a clinical perspective, a strategy that targets
biofilm inhibition should be less susceptible than conventional
antibiotic treatment to the emergence of resistance in pathogens,
particularly as metabolic processes and bacterial growth are not
directly targeted.
In this study, we investigated the anti-biofilm activity
of P. aeruginosa alkylhydroxyquinolone (AHQ) autoinducers
against A. fumigatus. Growth was unaffected, while biofilm
biomass and structure was significantly altered in the presence
of both 2-heptyl-4-quinolone (HHQ) and 2-heptyl-3-hydroxy-
4-quinolone (PQS). Having established the activity of the
parent molecules, a suite of analogs was tested for anti-
biofilm activity and lead compounds were identified that
retained activity against A. fumigatus. The synthesis of new
compounds incorporating decorations on the anthranilate ring
identified further lead compounds with activity comparable to
the parent HHQ molecule, providing important insights into the
structure function relationship underpinning the suppression of
fungal biofilms. Importantly, anti-biofilm activity was retained
against clinical isolates from a pediatric cohort, providing a
framework for further functionalization and future clinical
implementation.
MATERIALS AND METHODS
Fungal and Bacterial Culture Conditions
Aspergillus fumigatus Af293 was routinely grown on Sabouraud
dextrose agar (SDA) in 100 ml cell culture flasks at 37◦C
for 3–4 days. Sputum samples from a pediatric CF cohort
(Cork University Hospital) were cultured on SDA plates
and incubated for 4–7 days at 37◦C. Conidia were collected
by scraping in PBS with 0.025% (v/v) Tween 20, and the
Internal Transcribed Spacer (ITS) region was amplified by
PCR using ITS4 (5′-TCCTCCGCTTATTGATATGC-3′) and
ITS5 (5′-GGAAGTAAAAGTCGTAACAAGG-3′) for taxonomic
identification. PCR reaction conditions were as follows: 30 cycles
of alternating denaturation (94◦C for 45 s), annealing (58◦C for
45 s), and extension (72◦C for 2 min). Yeast cultures of Candida
albicans were routinely grown on yeast peptone dextrose (YPD)
agar and were cultured at 30◦C overnight. Bacterial cultures of
P. aeruginosa containing the pLP0996 pqsA-lacZ promoter fusion
were maintained on Luria Bertani (LB) plates supplemented with
carbenicillin (200 µg/ml), and routinely grown at 37◦C.
Spore Capture and Biofilm Assay
Conidia were harvested by flooding the surface of the agar
plates with 5 ml PBS (Oxoid) containing 0.025% (v/v) Tween
20 and gently moving the liquid over the surface of the fungal
lawn. The conidial suspension was transferred into a 25 ml
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sterile container and conidia were counted using a Neubauer
haemocytometer and light microscope. Conidia were adjusted to
the required concentration in RPMI 1640 (Sigma) buffered to pH
7.0 with 0.165 M MOPS immediately prior to biofilm formation
analysis.
To assess biofilm formation, counted A. fumigatus spores
(1 × 105) in MOPS buffered RPMI 1640 were inoculated into
24- and 96-well plates and grown overnight in the presence
of 100 µM HHQ, PQS and the compound collection. After
24 h, the media was removed and the biofilm washed twice
with distilled water after which 0.1 % crystal violet (CV) was
added to each well and allowed to stand for 1 h at room
temperature. The CV was removed and all wells washed in a water
bath by inversion. Ethanol was added to each well to solubilize
biofilms after which samples were read on a spectrophotometer
at OD595nm.
Analysis of preformed biofilms (24 h) was carried out
by allowing biofilms to establish in buffered RPMI, or
compound/carrier treated RPMI as described above. Disks were
removed and washed gently in PBS to remove unattached cells.
Disks from the buffered RPMI wells were transferred into 1 ml
of buffered RMPI with 100 µM HHQ, 1, or methanol control.
In tandem, disks from pre-treated wells were also transferred
and treated again with their respective compound or methanol
control. All plates were incubated for 24 h at 37◦C and biofilm
quantified as before.
Staining and Microscopy
Aspergillus fumigatus spores (1 × 105) were inoculated onto
plastic coverslips in 24 well plates and grown in the presence
of analogs overnight at 37◦C in RPMI buffered with MOPS
pH 7.0. After 24 h, plastic coverslips were washed once in PBS
and stained. Calcofluor (1 mg/ml) and 10% (w/v) potassium
hydroxide were added drop-wise to coverslips, washed in PBS,
mounted, and viewed. Concanavalin A (Con A) and FUN-1
were added at 50 µg/ml in 1 ml PBS and incubated at 37◦C for
30 min. All imaging was carried out on a Zeiss LSM5 confocal
microscope. Confocal images were recorded under a bright field
lens using ×20 objective magnification. Filter cubes facilitating
fluorescent imaging were used to record images for Calcofluor
at Abs405nm, Con A at Abs488nm and FUN-1 at Abs543nm. All
images were captured using the Zeiss HBO-100 microscope
illuminating system, processed using the Zen AIM application
imaging program and converted to JPG using Axiovision 40 Ver.
4.6.3.0.
Growth Assays
Aspergillus fumigatus Af293 was grown in RPMI buffered media
or YPD to assess sensitivity to HHQ, PQS, and lead analogs. Spore
suspensions were collected from SDA plates in PBS Tween 20
(0.025%), counted using a haemocytometer, and inoculated into
fresh YPD to a cell count of 1× 105 spores/ml. Spore suspensions,
either treated with lead compounds, carrier solvent, or untreated,
were then added in quadruplicate to 96-well plates and incubated
with gentle agitation for 24 h. The OD405nm was determined
spectrophotometrically.
Promoter Fusion Analysis
Alkylhydroxyquinolone signaling was monitored using the pqsA-
lacZ promoter fusion pLP0996 in both the wild-type PAO1
strain and its isogenic pqsA− mutant (McGrath et al., 2004).
Cells from overnight cultures were transferred to fresh LB media
(carbenicillin 200 µg/ml) to a starting OD600 nm 0.02 in the
presence of compounds 20–24 (100 µM) or equivalent volumes
of DMSO. Samples were taken at late log phase growth and
β-galactosidase activity was measured as before (Reen et al.,
2016).
Cytotoxicity Assays
Lactate dehydrogenase (LDH) release from HeLa (cervical
epithelial adenocarcinoma) cells was assayed as a measure of
cytotoxicity using an LDH colorimetric kit (Roche) according
to manufacturers’ instructions. HeLa cells were seeded into 96
well plates and treated with methanol (control) and analogs.
Following a 16 h incubation at 37◦C and 5% CO2, supernatants
were removed and added to catalyst reaction mixture in a fresh
plate and further incubated at 37◦C and 5% CO2 for 30 min
to allow for color development. After this period, the plate
was analyzed by measuring the absorbance on a microplate
spectrophotometer at OD490nm.
XTT Biofilm Assays
The C. albicans biofilm response to analogs was assessed
using the XTT [2,3-Bis-(2-Methoxy-4-Nitro-5-Sulfophenyl)-2H-
Tetrazolium-5-Carboxanilide] assay in 96 well plates at 37◦C.
After overnight growth in the presence of methanol (control)
and analogs, C. albicans biofilms were treated with 100 µl
freshly prepared XTT (Sigma) and menadione (Sigma). After
a 2 h incubation at 37◦C, biofilm formation was determined
by measuring the absorbance at OD492nm on a microplate
spectrophotometer.
Statistical Analysis
Data presentation and statistical analysis was performed using
the GraphPad Prism v5.03 software package or the Bootstratio
algorithm (Cleries et al., 2012).
Compound Synthesis
The synthesis of HHQ, PQS (Pesci et al., 1999; McGlacken et al.,
2010) and other HHQ-based analogs (Reen et al., 2012, 2015,
2016) was carried out via previously described methods. Novel
compounds and compounds which required modified syntheses
are described vide infra and in the Supplementary Data Sheet.
Ethics Statement
Sputum samples were collected from pediatric patients attending
the CF clinic at Cork University Hospital, Ireland. This study
was carried out in accordance with the recommendations
of the Clinical Research Ethics Committee of the Cork
Teaching Hospitals (CREC), with written informed consent
from all subjects. All subjects gave written informed consent
in accordance with the Declaration of Helsinki. The protocol
was approved by the CREC and all samples were handled in
accordance with the approved guidelines.
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RESULTS
P. aeruginosa Signal Molecules Interfere
with Biofilm Formation in A. fumigatus
The P. aeruginosa signaling molecules HHQ and PQS have
previously been shown to possess interkingdom activity,
influencing the phenotypic and transcriptional behavior of both
microbes and higher order organisms (Reen et al., 2011; Tashiro
et al., 2013; Trejo-Hernandez et al., 2014), including mammalian
cells (Kim et al., 2010). While the P. aeruginosa secretome
has previously been shown to suppress biofilm formation in
A. fumigatus (Mowat et al., 2010), the extent of the active
components remained to be defined. Our previous finding that
HHQ suppressed biofilm formation in the pathogenic yeast,
C. albicans (Reen et al., 2011), led us to investigate the anti-
biofilm activity of these signals against A. fumigatus. Addition of
either HHQ or PQS to the model strain A. fumigatus Af293 led to
a significant reduction in attachment to the wells of polystyrene
plates (Figure 1A). As expected, loss of the alkyl chain led to a
significant reduction in the potency of this anti-biofilm activity,
consistent with the functional requirement for this feature in
AHQ signaling.
In order to visualize the biofilm structures, attached cells were
treated with specific intracellular stains to assess impact on key
cellular components. These included cellulose and chitin with
Calcofluor; live cellular vacuolar stain FUN-1 which functions
as a live/dead stain; and lectin (carbohydrate) structures with
Concanavalin A. Confocal microscopic analysis confirmed the
effect of HHQ and PQS on formation of biofilm mass and
revealed a significant reduction and disruption of hyphal
development (Figure 1B). Cells treated with either HHQ or PQS
appeared locked in a spore form, with minimal evidence for
formation of hyphal structures, and the absence of the interwoven
network characteristic of A. fumigatus.
Structurally Modified AHQ Analogs
Retain Anti-biofilm Activity
Having established that both HHQ and PQS interfered with
biofilm formation, a suite of 4-quinolone analogs, bearing diverse
structural features (Supplementary Figure S1), were tested for
anti-biofilm activity toward A. fumigatus. Analogs included
modifications at the C3 and C4 positions, on the anthranilate
ring, and of the alkyl chain length, while substitutions were
predominantly with halogen, n-hexyl, methyl or methoxy groups.
The results of this analysis revealed that an exquisite degree
of structural conservation is required for AHQ inter-kingdom
activity (Figure 2A). Of these, compound 5 (n-hexyl at C6) and
compound 12 (methoxy at C7) gave the greatest reduction in
biofilm formation. Compound 14, in which the alkyl chain length
was extended relative to the parent molecule HHQ, retained its
anti-biofilm activity, while addition of halogen groups at C3 led
to loss of anti-biofilm activity. Addition of a methoxy (3) or
methyl (4) group to the C6 position of HHQ with a seven carbon
alkyl chain led to loss of anti-biofilm activity (Figure 2B), while
activity was retained in methoxy (11) and halogen (17) modified
equivalents upon extension of the alkyl chain to nine carbons.
Isolation of quinolones with substituents at C5 is difficult,
as the corresponding regioisomer (at C7) is also formed in
the Conrad-Limpach cyclisation step. Thus we chose to focus
on symmetrical aniline precursors, which allowed for further
elaboration at the 6-position. Compounds were synthesized with
Br (20), CO2C2H5 (21), an electron withdrawing F (22), and
an electron donating bulky C–C3H9 (23) at the C6 position
(Figure 3). Use of the 3,5-dimethyl aniline precursor gave a
C5–C7 substituted CH3 (24). All analogs were assessed for
antagonism of biofilm formation in A. fumigatus Af293. While
two of the substituted analogs, 20 and 23, had lost their anti-
biofilm activity, compounds 21, 22, and 24 retained activity
against the fungus, suppressing biofilm formation to the same
degree as lead compounds (Figure 4). It is clear that the structural
organization of the anthranilate ring components is of critical
importance to the anti-biofilm activity. The retention of anti-
biofilm formation by analogs functionalized at the C6 and C8
positions was particularly interesting given that halogenation
of these positions had previously been shown to enhance
antagonism of PQS signaling in P. aeruginosa (Ilangovan et al.,
2013).
Microscopic analysis of biofilms formed on plastic coverslips
in the presence of selected compounds confirmed the disruption
of hyphal structures in Af293 (Figure 5). Staining with Calcofluor
revealed the absence of intact hyphal networks in samples
treated with compounds 1, 12, 21, and 24 while inactive
compounds 3 and 15 did not affect this phenotype. This anti-
biofilm activity was shown to be independent of any impact
on growth of Af293, with the exception of compound 2 which
reduced the final OD600 nm reached by 0.1 unit (Supplementary
Figure S2).
Having determined that the alkylhydroxyquinolone derivative
compounds could suppress biofilm formation in A. fumigatus,
the next stage was to assess whether or not they could affect
pre-formed A. fumigatus biofilms. The addition of HHQ or 1 to
preformed biofilms on plastic disks led to a reduction relative
to the methanol control, although only 1 reached statistical
significance (Figure 6). Pre-treatment from the outset with either
HHQ or 1 led to a marked reduction in biofilm formation on
disks when compared with the control sample, further evidence
that both attachment and the development of hyphal biofilms
may be key targets for the lead compounds.
C6-Modified Analogs Exhibit
Non-cytotoxic A. fumigatus Specific
Activity
Any assessment of the utility of these compounds as anti-biofilm
agents must consider the origin of the parent molecules HHQ and
PQS as co-inducers of AHQ mediated virulence in P. aeruginosa.
Both HHQ and PQS control multiple virulence phenotypes
through activation of the PqsR transcriptional regulator (Xiao
et al., 2006). Previously, we have shown that several of the lead
analogs described here e.g., 1 and 2 are non-agonists of the
AHQ signaling system in P. aeruginosa, are selectively non-
cytotoxic, and are also effective biofilm blockers in C. albicans
(Supplementary Table S1) (Reen et al., 2016). Therefore, this
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FIGURE 1 | Suppression of A. fumigatus biofilm formation in response to HHQ and PQS. (A) Biofilm assays using crystal violet (CV) staining. mPQS and
mHHQ refer to the parent compounds with the C7 alkyl chain removed. RPMI constitutes the untreated sample whereby no compound or carrier has been added.
Data is presented as mean fold change (+/− SEM) of Abs595nm relative to untreated cells. Data is representative of five independent biological replicates. Statistical
significance using methanol treated cells as reference is represented by one way ANOVA with post hoc Bonferroni correction (∗p < 0.05, ∗∗p < 0.005;
∗∗∗P < 0.001). (B) Confocal microscopic analysis (×20) of biofilm formation on plastic coverslips. Staining was performed using Calcofluor-1 (cellulose and chitin),
Concanavalin A (live cellular vacuoles), and FUN-1 (lectins/carbohydrates).
analysis was extended to the newly synthesized compounds 20–
24 to provide a comprehensive profile of all the compounds
described in this study. Addition of compounds 21, 23, and 24
did not lead to increased pqsA promoter activity in a PAO1
pqsA− mutant strain indicating that they are non-agonists of the
PqsR virulence system (Figure 7A). In contrast, compounds 20
and 22 significantly increased expression relative to the control,
suggesting that further modification would be required to silence
this activity. In spite of being ineffective PqsR ligands, none of the
five analogs were capable of interfering with AHQ signaling in the
wild-type PAO1 strain, as seen with the comparable activity of the
pqsA promoter in both treated and untreated cells (Figure 7B).
In order to determine whether or not the anti-biofilm activity
extends to other fungal pathogens, C. albicans was tested for
biofilm formation in the presence and absence of compounds
20–24 (Figure 7C). None of the compounds were found to be
active against C. albicans biofilm formation, in contrast to some
of the other lead compounds identified in this study, such as
1 and 2 (Reen et al., 2016). Further extending the profile and
characterization of these compounds, cytotoxicity was measured
in a host cell line (Figure 7D). Only compound 24 elicited any
measurable degree of cytotoxicity, and this was to a lesser extent
than the parent molecule HHQ. The other four analogs were
comparable to the methanol control.
AHQ Analogs Block Biofilm in Clinical
A. fumigatus Isolates
There is a growing realization that the genomes of clinical isolates
can vary markedly from typed environmental strains, with
niche-specific selective pressures manifesting in considerable
heterogeneity, even within species. This led us to investigate
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FIGURE 2 | Biofilm formation in A. fumigatus cells following incubation with (A) active and (B) inactive AHQ analogs. CV stained multi-well biofilm assays.
Data is presented as mean fold change (+/− SEM) in Abs595nm relative to untreated treated cells and includes at least five independent biological replicates.
Statistical significance using methanol treated cells as reference is represented by one way ANOVA with post hoc Bonferroni correction (∗∗∗P < 0.001).
FIGURE 3 | Synthesis pipeline for anthranilate ring analogs 20–24.
the effectiveness of the lead compounds against clinical isolates
from a pediatric CF cohort, each of which exhibited significant
wrinkling of the mycelial mat compared to the smoothness
of Af293 (Figure 8). Both HHQ and PQS were capable of
suppressing biofilm formation in each of the clinical isolates. It
was notable, however, that the suppression of biofilm formation
was not to same extent as that seen against the lab strain
Af293, suggesting some degree of tolerance or adaptation in
the clinical isolates (Figure 8). Lead compounds were also
found to be effective against biofilm formation in clinical
strains, underpinning their suitability for further therapeutic
development (Figure 9).
The structural impact of lead compounds on biofilm
formation in both Af293 and the clinical isolates was assessed
using confocal microscopy of calcofluor stained cells. As
expected, anti-biofilm compounds disrupted the formation of
hyphal structures, while inactive compounds (e.g., 23) did not
markedly affect this phenotype. In general, active compounds
(e.g., 2 and 24) appeared to lock the fungal cells in the spore state,
with little or no evidence for hyphal development (Figure 10).
Although present in some of the clinical isolates (e.g., CFBRC2
and CFBRC3, 24), hyphal structures were weak and sparse,
indicating that a key mode of action of these compounds is the
prevention of the hyphal switch.
DISCUSSION
Exposure of immunocompromised individuals to A. fumigatus
can result in significant morbidity and even mortality in severe
cases. The incidence is on the rise owing largely to the
increased prevalence of respiratory conditions such as asthma,
increased frequency of lung transplantation, and the ongoing
use of immunosuppressive therapies. In many of these cases,
A. fumigatus adopts a biofilm lifestyle, enhancing its persistence
and contributing directly to morbidity and mortality associated
with these infections. A. fumigatus has recently been associated
with medical device infections (Ramage et al., 2012; Ramage
and Williams, 2013; Nett and Andes, 2015). Cases of serious
biomaterial-related infections of joint replacements, catheters,
heart valves, cardiac pace makers, and breast augmentation
implants have been reported. Often, high risk invasive surgical
procedures are used to treat these A. fumigatus infections, as
the formation of biofilm structures and the associated increased
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FIGURE 4 | Anti-biofilm activity of anthranilate ring substituted
compounds. Data is presented as mean fold change (+/− SEM) of Abs595nm
relative to untreated cells and includes five independent biological replicates.
Statistical significance relative to methanol treated cells is represented by one
way ANOVA with post hoc Bonferroni correction (∗p < 0.05; ∗∗p < 0.005;
∗∗∗P < 0.001).
FIGURE 5 | Microscopic analysis of Af293 biofilm formation on plastic
coverslips in the presence of selected active and inactive AHQ
analogs.
rate of antifungal resistance renders conventional treatment
ineffectual (Desai et al., 2014; Nett and Andes, 2015). Antifungal
tolerance in fungal infections has been attributed to the secretion
of an extracellular polymeric matrix and increased activity of
eﬄux pumps (Mowat et al., 2008; Rajendran et al., 2013).
Therefore, therapies that combat biofilms directly are likely to
enhance the survival and life expectancy of infected individuals.
In this study we have shown that two signal molecules
secreted by the nosocomial pathogen P. aeruginosa can
suppress biofilm formation in A. fumigatus. This may be a
consequence of the proximity in which these organisms co-
exist in clinical and environmental niches, including the lungs
of immunocompromised patients and the plant ecosystem.
Interactions between co-existing organisms have been widely
reported, with signaling molecules showing activity ranging from
inter-species to inter-kingdom (Reen et al., 2011; Chen et al.,
2014; Michelsen et al., 2014; Kendall and Sperandio, 2016). Both
FIGURE 6 | Anti-biofilm activity of lead compounds on preformed
A. fumigatus Af293 biofilms on plastic disks. Data presented is the mean
(+/− SEM) of six independent biological replicates. Statistical analysis is
performed by one way ANOVA with post hoc Bonferronic correction
(∗p < 0.05; ∗∗∗p < 0.001).
HHQ and PQS were capable of interfering with the formation
of A. fumigatus biofilms, leading to reduced biomass and the
absence of intact hyphal structures in treated cells. Derivatization
of the quinolone framework at the C6 and C8 positions
revealed the anthranilate ring to be particularly important in
the anti-biofilm activity. Several of these compounds have no
agonistic activity toward P. aeruginosa virulence, unlike the
parent molecules HHQ and PQS, thus presenting a viable
framework for therapeutic development against medical device
fungal pathogens [Figure 7 and (Reen et al., 2016)]. Furthermore,
they are selectively non-cytotoxic to host cell lines, further
supporting their development as viable molecular therapeutics.
The next stage in the development of these lead compounds will
be the characterization of the molecular mechanism(s) through
which they elicit their anti-biofilm activity. One approach
will be to investigate the possibility of fungal sensory and
signal transduction systems that may be involved in perception
of alkylhydroxyquinolones and transduction of that response
to exist in a non-hyphal growth state. Alternatively, alkyl-
quinolones, and PQS in particular, have also been reported
previously to possess both pro- and anti-oxidant activity, while
interaction with lipopolysaccharide, cellular membranes, and
membrane vesicles has also been reported in several bacterial
species (Haussler and Becker, 2008; Mashburn-Warren et al.,
2009).
The modulation of A. fumigatus biofilm by HHQ and
PQS adds another layer of complexity to the interkingdom
interactions that are characteristic of mixed P. aeruginosa fungal
communities. Phenazines, a redox active toxin controlled by
PQS and secreted by P. aeruginosa reportedly undergo chemical
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FIGURE 7 | Profiling the spectrum of activity of compounds 20–24. Promoter fusion analysis of the pqsA-lacZ pLP0996 plasmid in (A) a PAO1 pqsA− mutant,
and (B) PAO1 wild-type strain, (C) XTT biofilm analysis of C. albicans and (D) LDH release cytotoxicity assays using HeLa cell lines. Data in all experiments is the
mean (+/− SEM) of at least three independent biological replicates. Statistical analysis was performed by one-way ANOVA with post hoc Bonferroni correction
(∗∗∗p ≤ 0.001).
transformation by A. fumigatus and C. albicans (Moree et al.,
2012; Chen et al., 2014). The AHL class of quorum sensing
signal has also been shown to play a role in modulating biofilm
formation in these fungal pathogens (McAlester et al., 2008;
Mowat et al., 2010), while HHQ and PQS have previously been
shown to modulate biofilm formation in C. albicans (Reen et al.,
2011, 2016). Apart from signal mediated interactions, there is
recent evidence to suggest that interspecies and interkingdom
interactions can foster mutability in co-existing organisms
(Michelsen et al., 2014; Trejo-Hernandez et al., 2014). It must
also be considered that microbial signals are just one factor in
the process of fungal biofilm formation in the host. Other factors
such as the availability of nutrients, host related factors such
as the immune system and the surface upon which the biofilm
will form, mechanical factors such as flow rate within the niche,
and the presence of dispersion agents can have a significant
influence on fungal biofilm formation. Notwithstanding this,
deciphering the chemical messages used by microbes themselves
to control the behavior of pathogenic species, without disrupting
the growth of the microbiome as a whole, remains a key goal in
the age of molecular based therapeutics (Figure 11). As a greater
understanding of the connection between microbiome dysbiosis
and disease status continues to emerge, the critical need for
therapeutics that retain the functionality of the core microbiome
becomes ever more relevant.
CONCLUSION
Microbial communities are founded on intricate and long-
evolved communication systems that determine the flux and
dynamics of particular species in response to local and
environmental cues. Therefore, deciphering these chemical
messages has the potential to deliver on the new and innovative
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FIGURE 8 | AHQs suppress biofilm formation in clinical isolates. (A) Morphological analysis of clinical A. fumigatus isolates. (B) Biofilm formation in
A. fumigatus treated cells following incubation with AHQ signals HHQ and PQS. Data is presented as mean fold change (+/− SEM) in OD595nm relative to methanol
treated cells and includes five independent biological replicates. Statistical significance is represented by Bootstratio analysis (∗p < 0.05; ∗∗p < 0.005; ∗∗∗P < 0.001).
FIGURE 9 | Biofilm formation in A. fumigatus clinical isolates following incubation with AHQ analogs. Data is presented as mean fold change (+/− SEM)
in OD595nm relative to methanol treated cells and includes at least three independent biological replicates. Statistical significance is represented by Bootstratio
analysis (∗p < 0.05; ∗∗p < 0.005; ∗∗∗P < 0.001).
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FIGURE 10 | CLSM analysis of biofilm formation in Af293 and clinical isolates in the presence of lead compounds 2 and 24. All data presented is
representative of three independent biological replicates.
FIGURE 11 | The lead compounds identified in this study address a key clinical need for alternatives to broad spectrum antifungals. Challenge: While
still the lead option for the management of microbial infections, broad spectrum growth limiting antifungals are increasingly being challenged by limiting factors
including antifungal resistance, the aggressive persistence of known pathogens in a biofilm lifestyle, and the collateral damage caused to the host microbiome
leading to dysbiosis, Solution: Exploiting new knowledge of cell–cell communication systems and utilizing synthetic chemistry approaches to generate suites of
derivatized compounds, has made possible the development of anti-biofilm small molecules that are selectively non-toxic in mammalian cell lines. These have the
potential to lock yeast and fungal pathogens such as A. fumigatus in the non-hyphal state, potentially rendering them more susceptible to immune challenge, and
enhancing the effectiveness of conventional antifungal compounds.
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alternatives being sought to conventional growth limiting
antibiotics. This is an attractive route to therapy due to the
chemical tractability of these signals, opening up avenues for
functionalization to improve activity and drug-ability of lead
compounds. The work described here is highly significant and
potentially relevant to several sectors within the clinical and
medical device arena where the occurrence of in vivo and
nosocomial Aspergillus infections is destructive from both a
human and financial perspective.
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